Impact of Dose and Sensitivity Heterogeneity on TCP

This present paper presents an analytical description and numerical simulations of the influence of macroscopic intercell dose variations and intercell sensitivity variations on the probability of controlling the tumour. Computer simulations of tumour control probability accounting for heterogeneity in dose and radiation sensitivity were performed. An analytical expression for tumor control probability accounting for heterogeneity in sensitivity was also proposed and validated against simulations. The results show good agreement between numerical simulations and the calculated TCP using the proposed analytical expression for the case of a heterogeneous dose and sensitivity distributions. When the intratumour variations of dose and sensitivity are taken into account, the total dose required for achieving the same level of control as for the case of homogeneous distribution is only slightly higher, the influence of the variations in the two factors taken into account being additive. The results of this study show that the interplay between cell or tumour variation in the sensitivity to radiation and the inherent heterogeneity in dose distribution is highly complex and therefore should be taken into account when predicting the outcome of a given treatment in terms of tumor control probability.

[1]  S Webb,et al.  A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. , 1993, Physics in medicine and biology.

[2]  Anders Brahme,et al.  Dose prescription and optimisation based on tumour hypoxia , 2009, Acta oncologica.

[3]  A. Brahme,et al.  Optimal dose distribution for eradication of heterogeneous tumours. , 1987, Acta oncologica.

[4]  D J Brenner,et al.  Dose, volume, and tumor-control predictions in radiotherapy. , 1993, International journal of radiation oncology, biology, physics.

[5]  M Zaider,et al.  Distribution of the number of clonogens surviving fractionated radiotherapy: a long-standing problem revisited , 2001, International journal of radiation biology.

[6]  Alexandru Daşu,et al.  Should single or distributed parameters be used to explain the steepness of tumour control probability curves? , 2003, Physics in medicine and biology.

[7]  S. Tucker,et al.  Improved models of tumour cure. , 1996, International journal of radiation biology.

[8]  J H Hendry,et al.  Time factors in larynx tumor radiotherapy: lag times and intertumor heterogeneity in clinical datasets from four centers. , 1999, International journal of radiation oncology, biology, physics.

[9]  H. Thames,et al.  How well is the probability of tumor cure after fractionated irradiation described by Poisson statistics? , 1990, Radiation research.

[10]  Yakovlev AYu.  Comments on the distribution of clonogens in irradiated tumors. , 1993, Radiation research.

[11]  J D Fenwick,et al.  Predicting the radiation control probability of heterogeneous tumour ensembles: data analysis and parameter estimation using a closed-form expression. , 1998, Physics in medicine and biology.

[12]  A. Nahum,et al.  Monte Carlo dose calculations and radiobiological modelling: analysis of the effect of the statistical noise of the dose distribution on the probability of tumour control , 2000, Physics in medicine and biology.

[13]  CHRIstINE HaRtING,et al.  Computer simulation of tumour control probabilities after irradiation for varying intrinsic radio-sensitivity using a single cell based model , 2010, Acta oncologica.

[14]  J Deasy,et al.  Poisson formulas for tumor control probability with clonogen proliferation. , 1996, Radiation research.

[15]  S Webb,et al.  Optimum parameters in a model for tumour control probability including interpatient heterogeneity. , 1995, Physics in medicine and biology.

[16]  Bengt K Lind,et al.  The influence of dose heterogeneity on tumour control probability in fractionated radiation therapy. , 2011, Physics in medicine and biology.

[17]  A. Nahum,et al.  The delta-TCP concept: a clinically useful measure of tumor control probability. , 1999, International journal of radiation oncology, biology, physics.

[18]  W S Kendal.  A closed-form description of tumour control with fractionated radiotherapy and repopulation. , 1998, International journal of radiation biology.

[19]  M Goitein,et al.  Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  J H Hendry,et al.  A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity. , 1998, International journal of radiation oncology, biology, physics.

[21]  M. Zaider,et al.  Tumour control probability: a formulation applicable to any temporal protocol of dose delivery. , 2000, Physics in medicine and biology.

[22]  M Goitein,et al.  Causes and consequences of inhomogeneous dose distributions in radiation therapy. , 1986, International journal of radiation oncology, biology, physics.